Literature DB >> 2903663

Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations.

B T Darras1, P Blattner, J F Harper, A J Spiro, S Alter, U Francke.   

Abstract

Following the strategy outlined in an accompanying paper, we studied 32 X-linked muscular dystrophy families (29 Duchenne [DMD] and three Becker [BMD] type) for abnormalities of HindIII and BglII fragments detected by the entire dystrophin cDNA. Twenty-one different single-intragenic deletions, and no duplications, were identified. The deletion endpoints were precisely mapped on the published HindIII fragment map. Detailed analysis of overlapping deletions led to clarification of the fragment order for some previously unsettled regions of the HindIII map and to the construction of a partial map of exon-containing BglII fragments. For the regions involved in deletions, the corresponding HindIII and BglIII fragments could be identified. Noncontiguous comigrating fragments were detected in two regions by careful analysis of the patterns in deletion patients. Four of the 21 deletions generated novel restriction fragments that facilitated detection of female carriers in these families. Twelve of the deletions had a breakpoint in one of the two large introns known to be the sites of breakpoint clusters. By combining deletions and RFLP analyses, we unequivocally identified the gamete that first carried the mutation in 13 families: eight oocytes and five sperm. Germ-line mosaicism previously detected in one male was confirmed by cDNA studies. In two additional families gonadal mosaicism was found in females. As evidence is accumulating for frequent mitotic origin of these deletion mutations, this phenomenon has to be considered when postulating mutational mechanisms and in genetic counseling of DMD/BMD families.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903663      PMCID: PMC1715543     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  Germinal mosaicism in Duchenne muscular dystrophy.

Authors:  S Wood; B C McGillivray
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

Review 2.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

4.  Duchenne muscular dystrophy: high frequency of deletions.

Authors:  R J Bartlett; M A Pericak-Vance; J Koh; L H Yamaoka; J C Chen; W Y Hung; M C Speer; M C Wapenaar; G J Van Ommen; E Bakker
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

5.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

Authors:  M Koenig; A P Monaco; L M Kunkel
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

6.  Cloning of a cDNA for steroid sulfatase: frequent occurrence of gene deletions in patients with recessive X chromosome-linked ichthyosis.

Authors:  J M Bonifas; B J Morley; R E Oakey; Y W Kan; E H Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA.

Authors:  B T Darras; M Koenig; L M Kunkel; U Francke
Journal:  Am J Med Genet       Date:  1988-03

8.  Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker.

Authors:  G J van Ommen; C Bertelson; H B Ginjaar; J T den Dunnen; E Bakker; J Chelly; M Matton; A J van Essen; J Bartley; L M Kunkel
Journal:  Genomics       Date:  1987-12       Impact factor: 5.736

9.  Duchenne and Becker muscular dystrophy mutations: analysis using 2.6 kb of muscle cDNA from the 5' end of the gene.

Authors:  T J Smith; S M Forrest; G S Cross; K E Davies
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

10.  Deletions of fetal and adult muscle cDNA in Duchenne and Becker muscular dystrophy patients.

Authors:  G S Cross; A Speer; A Rosenthal; S M Forrest; T J Smith; Y Edwards; T Flint; D Hill; K E Davies
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  54 in total

1.  ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy.

Authors:  K M Fitzgerald; G W Cibis; A H Gettel; R Rinaldi; D J Harris; R A White
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

2.  DNA analysis in Turkish Duchenne/Becker muscular dystrophy families.

Authors:  E Battaloğlu; M Telatar; F Deymeer; P Serdaroğlu; F Kuseyri; C Ozdemir; M Apak; A Tolun
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

3.  Quantitative Southern blot analysis in the dystrophin gene of Japanese patients with Duchenne or Becker muscular dystrophy: a high frequency of duplications.

Authors:  Y Hiraishi; S Kato; T Ishihara; T Takano
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

4.  Extended electrophoresis resolves the dystrophin gene 5.2-kbp cDMD4-5a/HindIII fragment into two bands.

Authors:  Y M Otto; P G Rothberg
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

5.  Theoretical considerations on germline mosaicism in Duchenne muscular dystrophy.

Authors:  T Grimm; B Müller; C R Müller; M Janka
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

6.  Molecular studies of deletions at the human steroid sulfatase locus.

Authors:  L J Shapiro; P Yen; D Pomerantz; E Martin; L Rolewic; T Mohandas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Duchenne muscular dystrophy in Wales: impact of DNA linkage analysis and cDNA deletion screening.

Authors:  A M Norman; M Upadhyaya; N S Thomas; K Roberts; P S Harper
Journal:  J Med Genet       Date:  1989-09       Impact factor: 6.318

8.  Informative microsatellite markers allow carrier detection in a Duchenne muscular dystrophy deletion pedigree in the absence of DNA from an affected boy.

Authors:  R I Richards; K Friend; E A Haan
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

9.  Spectrum of small mutations in the dystrophin coding region.

Authors:  T W Prior; C Bartolo; D K Pearl; A C Papp; P J Snyder; M S Sedra; A H Burghes; J R Mendell
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

10.  Heterozygotic gene expression in endomyocardial biopsies: a new diagnostic tool confirms the Duchenne carrier status.

Authors:  M Schmidt-Achert; P Fischer; W Müller-Felber; H Mudra; D Pongratz
Journal:  Clin Investig       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.